Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis

Autor: Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, Raad JJ, Jarosova K, Anton-Lopez J, Macku M, Otero Escalante WJ, Rutkowska-Sak L, Trauzeddel R, Velez-Sanchez PJ, Wouters C, Wajdula J, Zang C, Bukowski J, Woodworth D, Vlahos B, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO)

Publikováno v: JOURNAL OF RHEUMATOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu

Objective. The main objective was to determine the 2-year clinical benefit and safety of etanercept (ETN) in children with the juvenile idiopathic arthritis (JIA) categories of extended oligoarthritis (eoJIA), enthesitis-related arthritis (ERA), or p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::253ecbc4120bde1fe0440e61b715f60e
https://www.jrheum.org/content/43/4/816.short

Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial

Autor: Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B, Campos L, Häfner R, Hofer M, Ozen S, Huemer C, Bae SC, Sztajnbok F, Arguedas O, Foeldvari I, Huppertz HI, Gamir ML, Magnusson B, Dressler F, Uziel Y, van Rossum MA, Hollingworth P, Cawkwell G, Martini A, Ruperto N, Pediatric Rheumatology International Trials O.r.g.a.n.i.s.a.t.i.o.n. Collaborators Murray KJ, Joos R, Wouters C, Oliveira S, Magalhães CS, Ferriani V, Mihaylova D, Dolezalova P, Lahdenne P, Minden K, Brik R, Gerloni V, Corona F, Falcini F, Zulian F, Alpigiani MG, Cortis E, Lepore L, Galasso R, Burgos Vargas R, Wulffraat N, ten Cate R, van Soesberger R, Asplin L, Flato B, Rygg M, Vesely R, Garcia Consuegra J, Merino R, Calvo I, Andersson Gare B, Saurenmann R, Sauvain MJ, Bakkaloglu A, Ozdogan H, Baildam E, Davidson J, Foster H, Walsh J, Hall A, Venning H, Woo P, Hashkes P, Kimura Y., ALESSIO, MARIA

Publikováno v: Annals of the rheumatic diseases, 69(8), 1479-1483. BMJ Publishing Group
Annals of the Rheumatic Diseases, 69(8), 1479-1483. BMJ Publishing Group

Objectives To determine whether baseline demographic, clinical, articular and laboratory variables predict methotrexate (MTX) poor response in polyarticular-course juvenile idiopathic arthritis. Methods Patients newly treated for 6 months with MTX en

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cebe6f0dbb5edce56220120ae094434e
http://hdl.handle.net/11588/519150

Miositis focal: a propósito de un caso en edad pediátrica y revisión de la literatura

Autor: Egea-Nadal P, Ocete G, Gamir Ml, Lorenzo-Sanz G, García-Villanueva M, García-Lacalle C

Publikováno v: Revista de Neurología. 27:505

INTRODUCTION AND CLINICAL CASE We present the case of a 13 years old boy with a year-old history of a painful tumour on the external and distal third of the right thigh. The imaging tests suggested a soft tissue tumour but the muscle biopsy revealed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6bcb552943f50b345e486267d267179a
https://doi.org/10.33588/rn.27157.97399

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study.

Autor: Ruperto N; IRCCS Istituto G. Gaslini Clinica Pediatrica e Reumatologia, UOSID Centro Trial, PRINTO, Genova, Italy., Lovell DJ; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio., Berman A; Universidad Nacional de Tucuman, San Miguel de Tucumán, Argentina., Ávila-Zapata F; Hospital Star Medica Merida, Yuc, Mexico., Horneff G; Asklepios Clinical Sankt Augustin, Sankt Augustin, Germany, and University of Cologne, Cologne, Germany., Alessio M; Universita di Napoli, Napoli, Italy., Becker ML; Duke University School of Medicine, Durham, North Carolina., Belot A; Hôpital Femme Mère Enfant, CHU de Lyon, Lyon, France., Burgos-Vargas R; Hospital General de México, Mexico City, Mexico., Gamir ML; Hospital Universitario Ramón y Cajal, Madrid, Spain., Goldenstein-Schainberg C; Hospital das Clinicas HCFMUSP, Universidade de São Paulo, São Paulo, Brazil., Scheibel IM; Grupo Hospitalar Conceição, Porto Alegre, Brazil., Terreri MT; Universidade Federal de São Paulo, São Paulo, Brazil., Zemel L; Connecticut Children's Medical Center, Hartford., Zhuo J; Bristol Myers Squibb, Princeton, New Jersey., Askelson M; Bristol Myers Squibb, Princeton, New Jersey., Wong R; Bristol Myers Squibb, Princeton, New Jersey., Martini A; Universita di Genova, Genova, Italy., Brunner HI; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.

Publikováno v: Arthritis care & research [Arthritis Care Res (Hoboken)] 2023 Aug; Vol. 75 (8), pp. 1804-1814. Date of Electronic Publication: 2023 Jan 29.